81305 Myd88 gene p.leu265pro vrnt
Also known as: MYD88 L265P testing, lymphoplasmacytic lymphoma genetic test
Myeloid Differentiation Primary Response gene (MYD88) gene analysis for the pathogenic p.Leu265Pro variant associated with lymphoplasmacytic lymphoma.
In Plain Language
Lymphoma mutation test; Blood cancer genetic marker
Clinical Context
Detects MYD88 L265P variant present in majority of lymphoplasmacytic lymphomas and Waldenstrom macroglobulinemia cases.
RVU Information
CPT 81305 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81305?
CPT 81305 (Myd88 gene p.leu265pro vrnt) is a Pathology & Lab code. Myeloid Differentiation Primary Response gene (MYD88) gene analysis for the pathogenic p.Leu265Pro variant associated with lymphoplasmacytic lymphoma.
Who uses CPT code 81305?
CPT 81305 is used by Pathology, Oncology, Hematology. Detects MYD88 L265P variant present in majority of lymphoplasmacytic lymphomas and Waldenstrom macroglobulinemia cases.
When is CPT 81305 used?
Detects MYD88 L265P variant present in majority of lymphoplasmacytic lymphomas and Waldenstrom macroglobulinemia cases.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.